---
ver: rpa2
title: An Uncertainty-Aware Dynamic Decision Framework for Progressive Multi-Omics
  Integration in Classification Tasks
arxiv_id: '2507.01032'
source_url: https://arxiv.org/abs/2507.01032
tags:
- uncertainty
- omics
- data
- classification
- view
- transformers
- self-attention
- retrieval-augmented-generation
- instruction-tuning
- parameter-efficient-finetuning
- mixture-of-experts
- chain-of-thought
core_contribution: This study presents an uncertainty-aware, dynamic decision framework
  for multi-omics classification that reduces testing costs by selectively integrating
  omics data based on confidence thresholds. The method employs evidential deep learning
  to quantify uncertainty at the single-omics level and uses Dempster-Shafer theory
  to fuse heterogeneous modalities only when necessary.
---

# An Uncertainty-Aware Dynamic Decision Framework for Progressive Multi-Omics Integration in Classification Tasks

## Quick Facts
- arXiv ID: 2507.01032
- Source URL: https://arxiv.org/abs/2507.01032
- Reference count: 5
- Key outcome: Reduces testing costs by >50% while maintaining diagnostic accuracy through uncertainty-aware, progressive multi-omics integration using evidential deep learning and Dempster-Shafer theory

## Executive Summary
This paper introduces an uncertainty-aware, dynamic decision framework for multi-omics classification that selectively integrates omics data based on confidence thresholds. The method employs evidential deep learning to quantify uncertainty at the single-omics level and uses Dempster-Shafer theory to fuse heterogeneous modalities only when necessary. Experimental results on four multi-omics datasets demonstrate that over 50% of cases achieve accurate classification using a single omics modality, with overall accuracy reaching 0.858Â±0.012 on ROSMAP and 0.856Â±0.010 on LGG.

## Method Summary
The framework uses evidential deep learning with Softplus activation to generate non-negative evidence vectors that map to Dirichlet distribution parameters. Belief masses and uncertainty masses are computed for each omics modality, then combined using Dempster-Shafer theory when single-modality uncertainty exceeds threshold tâ‚. A second threshold tâ‚‚ determines whether to proceed to full tri-omics integration. Thresholds are optimized via grid search to maximize classification accuracy while minimizing the number of modalities required.

## Key Results
- Over 50% of cases achieve accurate classification using a single omics modality (ROSMAP: 68.87%, LGG: 47.06%, KIPAN: 92.42%, BRCA: 60.08%)
- Overall accuracy reaches 0.858Â±0.012 on ROSMAP and 0.856Â±0.010 on LGG with uncertainty-aware integration
- The framework maintains diagnostic performance comparable to full-omics models while reducing testing costs through selective integration

## Why This Works (Mechanism)

### Mechanism 1
- Claim: Evidential deep learning enables single-pass uncertainty quantification without stochastic sampling.
- Mechanism: Replace Softmax with Softplus activation to generate non-negative evidence vectors e_k^v, map to Dirichlet parameters d_k^v = e_k^v + 1, then compute belief masses B_k^v = e_k^v / S_v and uncertainty mass U_v = K / S_v where S_v is total Dirichlet strength. Higher evidence â†’ higher belief; lower total evidence â†’ higher uncertainty.
- Core assumption: Dirichlet distribution appropriately models predictive uncertainty for multi-class omics classification; evidence values correlate with discriminative power.
- Evidence anchors:
  - [abstract] "utilizing subjective logic to quantify both the belief masses and uncertainty mass of classification results"
  - [section 3.1] "we refine the activation functions of neural networks to generate Dirichlet distribution parameters... Softplus(ð‘¥) = ln (1+ ð‘’ð‘¥)... ensures strictly positive outputs"
  - [corpus] Corpus papers emphasize GNN-based integration but do not address evidential uncertainty; this mechanism is distinct to the current work.
- Break condition: If uncertainty estimates don't correlate with prediction correctness (i.e., incorrect predictions show low uncertainty), the evidential calibration fails.

### Mechanism 2
- Claim: Dempster-Shafer fusion reduces uncertainty by amplifying agreement across modalities while preserving conflict awareness.
- Mechanism: Combine belief masses from multiple views using Dempster's rule: B_k = (1/(1-C)) Ã— (B_k^1Ã—B_k^2 + B_k^1Ã—U_2 + B_k^2Ã—U_1), where C = Î£ B_i^1Ã—B_j^2 (iâ‰ j) is conflict coefficient. Low conflict â†’ amplified consensus â†’ reduced fused uncertainty U = (1/(1-C)) Ã— U_1Ã—U_2.
- Core assumption: Omics modalities provide independent evidence; conflict coefficient C accurately captures cross-modal disagreement rather than noise artifacts.
- Evidence anchors:
  - [abstract] "uses Dempster-Shafer theory to fuse heterogeneous modalities only when necessary"
  - [section 3.2] "When the conflict ð¶ is low, the combination rule amplifies agreement and effectively reduces uncertainty"
  - [corpus] MoRE-GNN (arXiv:2510.06880) uses attention for multi-omics fusion but lacks explicit uncertainty-aware combination rules.
- Break condition: If modalities are highly conflicting (C â†’ 1), normalization factor 1/(1-C) becomes unstable; fusion may produce unreliable results.

### Mechanism 3
- Claim: Threshold-driven progressive integration achieves cost reduction while maintaining diagnostic accuracy.
- Mechanism: Define thresholds t_1 and t_2 via grid search (100 values each) optimizing accuracy. If single-view uncertainty u' â‰¤ t_1, accept prediction; else if dual-view u'' â‰¤ t_2, use fused result; else proceed to full tri-view integration. Thresholds are dataset-specific.
- Core assumption: Uncertainty monotonically decreases with additional modalities for uncertain cases; optimal thresholds generalize within dataset cohorts.
- Evidence anchors:
  - [abstract] "over 50% of cases achieved accurate classification using a single omics modality"
  - [section 4.4, Table 5] ROSMAP: 68.87% single-view, LGG: 47.06% single-view, KIPAN: 92.42% single-view, BRCA: 60.08% single-view
  - [corpus] Corpus papers do not address dynamic/cost-aware testing strategies; they assume full multi-omics availability.
- Break condition: If additional modalities introduce noise rather than signal, uncertainty may increase post-fusion (observed in Figure 5 for some cases); threshold logic should then favor earlier-stage predictions.

## Foundational Learning

- **Dirichlet Distribution**
  - Why needed here: Forms the probabilistic backbone for evidential learning; parameters represent evidence concentration over K classes.
  - Quick check question: Can you explain why d_k = e_k + 1 guarantees valid Dirichlet parameters?

- **Subjective Logic (Belief/Uncertainty Mass)**
  - Why needed here: Provides the formal framework converting Dirichlet parameters to interpretable belief masses (class support) and uncertainty mass (model ignorance).
  - Quick check question: Given B_k = e_k/S and U = K/S, what happens to uncertainty when total evidence S increases?

- **Dempster-Shafer Theory**
  - Why needed here: Enables principled fusion of uncertain evidence from multiple sources without requiring probabilistic independence.
  - Quick check question: If two views have high conflict (C close to 1), how does the normalization factor affect fused belief?

## Architecture Onboarding

- **Component map:**
  - Input: Multi-omics feature vectors (mRNA, DNAmethy, miRNA) per patient
  - Single-view MLPs â†’ Softplus activation â†’ Evidence vectors e_k^v
  - Dirichlet parameter mapping (d_k^v = e_k^v + 1)
  - Belief/uncertainty computation (B_k^v, U_v)
  - DST fusion module (pairwise Dempster combination)
  - Threshold comparator (t_1, t_2)
  - Loss: L_ace + Î·_t Ã— KL divergence

- **Critical path:**
  1. Train single-view evidential networks with combined loss
  2. Compute uncertainty U_v for each modality on validation set
  3. Grid search thresholds t_1, t_2 maximizing correct classifications
  4. Deploy dynamic inference: single â†’ dual â†’ triple based on thresholds

- **Design tradeoffs:**
  - Threshold granularity: 100-point grid search is computationally feasible but may miss local optima; increase if validation set is large.
  - Modality ordering: Paper uses fixed order (primary â†’ secondary â†’ tertiary); dataset-specific ordering could improve efficiency but requires prior knowledge.
  - KL annealing: Î·_t schedules from 0â†’1; premature increase may suppress evidence learning; monitor calibration curves.

- **Failure signatures:**
  - High uncertainty on correct predictions (miscalibration) â†’ check loss balancing, increase training epochs before KL activation
  - Conflict coefficient C approaching 1 during fusion â†’ modalities may be contradictory; consider modality selection or weighted DST variants
  - Stage 3 over-utilization â†’ thresholds too strict; re-calibrate on held-out validation

- **First 3 experiments:**
  1. Single-view baseline: Train individual evidential MLPs per omics type; report accuracy, F1, uncertainty distribution. Verify B_k + U = 1 constraint.
  2. Threshold sensitivity: Vary t_1 from min(u') to max(u') in 10 increments; plot accuracy vs. single-view utilization rate. Identify "elbow" point.
  3. Ablation on DST: Compare DST fusion vs. simple probability averaging for dual-view; report uncertainty reduction and conflict coefficient distribution.

## Open Questions the Paper Calls Out
None

## Limitations
- **Reproducibility Gaps**: Critical implementation details including MLP architecture specifications, training hyperparameters, data preprocessing protocols, and cross-validation methodology are not specified.
- **Threshold Calibration Validity**: The grid search approach for determining tâ‚ and tâ‚‚ optimizes accuracy but may not generalize to unseen patient cohorts across different population demographics or disease progression stages.
- **Modality Ordering Assumption**: The framework assumes a fixed order of omics integration without justifying this selection or exploring alternative ordering strategies that might yield better cost-accuracy tradeoffs.

## Confidence
**High Confidence** - The core theoretical framework combining evidential deep learning with Dempster-Shafer fusion is mathematically sound. The demonstration that single-omics modalities can resolve over 50% of cases while maintaining diagnostic accuracy is well-supported by reported experimental results.

**Medium Confidence** - The specific accuracy and uncertainty reduction metrics depend on unreported implementation choices. While the framework's effectiveness is clear, exact numerical performance is tied to architectural and training decisions not fully specified.

**Low Confidence** - The cost-effectiveness claims in real clinical settings require validation beyond controlled datasets. The framework assumes omics availability at all stages, but doesn't address practical constraints like omics generation time or batch processing requirements.

## Next Checks
1. **Cross-Cohort Threshold Transferability** - Test whether tâ‚ and tâ‚‚ values optimized on ROSMAP remain effective on LGG, BRCA, and KIPAN datasets. Measure accuracy degradation when using fixed vs. dataset-specific thresholds across all four cohorts.

2. **Ablation on Modality Ordering** - Systematically evaluate all 6 possible orderings of the three omics modalities through threshold optimization. Compare cost-accuracy tradeoffs to identify if the paper's assumed ordering is optimal or merely conventional.

3. **Conflict Coefficient Distribution Analysis** - For each dataset, analyze the distribution of conflict coefficients C during DST fusion. Determine what percentage of cases exceed critical thresholds (e.g., C > 0.5 or C > 0.8) and assess whether the normalization factor 1/(1-C) remains stable or indicates problematic modality conflicts.